PuSH - Publication Server of Helmholtz Zentrum München

Hofmann, S.M. ; Havel, P.J.*

The good, the bad, and the unknown: Fructose and FGF21.

Mol. Metab. 4, 1-2 (2015)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
In this issue of Molecular Metabolism, Dushay et al. report new results demonstrating fructose ingestion in humans acutely and robustly raises circulating levels of fibroblast growth factor 21 (FGF21) [1], a recently discovered hormone that has been proposed to have beneficial effects on metabolic health, including reduction of body weight and improvements of glucose and lipid metabolism [2]. People suffering from the metabolic syndrome have higher baseline circulating FGF21 levels and exhibit a larger increase of plasma FGF21 concentrations following an oral fructose load.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Editorial
Corresponding Author
ISSN (print) / ISBN 2212-8778
e-ISSN 2212-8778
Quellenangaben Volume: 4, Issue: 1, Pages: 1-2 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam
Non-patent literature Publications
Reviewing status Peer reviewed